Clinical Trial Update: A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI [NA]

View source ↗

Summary

A multi-center pediatric trial investigating a stem cell-derived product for immunomodulatory dysregulation in acute kidney injury has been terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SCD for Immunomodulatory Dysregulation

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Acute Kidney Injury | NA | Status: TERMINATED | Results posted: 2024-01-10